---
figid: PMC6594147__BJH-185-25-g001
figlink: /pmc/articles/PMC6594147/figure/bjh15778-fig-0001/
number: Figure 1
caption: Dysregulated immune response in the primary mediastinal B‐cell lymphoma (PMBCL)
  tumour microenvironment. Activating (red) genetic lesions/copy number gains and
  inactivating (blue) gene mutations in components of the JAK‐STAT signalling pathway
  diminish tumour immunogenicity via upregulation of programmed death ligands (PDLs)
  and C‐C motif chemokine ligand 17 (CCL17). Microdeletions in CD58 and mutations/structural
  rearrangements in class II major histocompatibility complex transactivator (CIITA)
  impair tumour antigenicity via downregulation of conjugate formation and major histocompatibility
  complex (MHC) class II, respectively. These immune escape strategies lead to T‐cell
  exhaustion, activation of suppressive T‐regulatory cells (Treg) and crippled immune
  surveillance. The impact of genetic aberrations in components of the nuclear factor
  kappa B (NF‐ĸB) signalling pathway on the PMBCL tumour microenvironment is not known.
pmcid: PMC6594147
papertitle: 'Biology and therapy of primary mediastinal B‐cell lymphoma: current status
  and future directions.'
reftext: Charlotte Lees, et al. Br J Haematol. 2019 Apr;185(1):25-41.
pmc_ranked_result_index: '33324'
pathway_score: 0.8696958
filename: BJH-185-25-g001.jpg
figtitle: Dysregulated immune response in the primary mediastinal B‐cell lymphoma
  (PMBCL) tumour microenvironment
year: '2019'
organisms: Homo sapiens
ndex: 4521e290-df14-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6594147__BJH-185-25-g001.html
  '@type': Dataset
  description: Dysregulated immune response in the primary mediastinal B‐cell lymphoma
    (PMBCL) tumour microenvironment. Activating (red) genetic lesions/copy number
    gains and inactivating (blue) gene mutations in components of the JAK‐STAT signalling
    pathway diminish tumour immunogenicity via upregulation of programmed death ligands
    (PDLs) and C‐C motif chemokine ligand 17 (CCL17). Microdeletions in CD58 and mutations/structural
    rearrangements in class II major histocompatibility complex transactivator (CIITA)
    impair tumour antigenicity via downregulation of conjugate formation and major
    histocompatibility complex (MHC) class II, respectively. These immune escape strategies
    lead to T‐cell exhaustion, activation of suppressive T‐regulatory cells (Treg)
    and crippled immune surveillance. The impact of genetic aberrations in components
    of the nuclear factor kappa B (NF‐ĸB) signalling pathway on the PMBCL tumour microenvironment
    is not known.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL4R
  - IL4
  - CCR4
  - CD2
  - CD8B
  - CD8A
  - CD58
  - CD4
  - FOXP3
  - HLA-DRB5
  - HLA-DRA
  - CIITA
  - NFKBIE
  - IL13
  - TRAF1
  - TRAF2
  - TRAF3
  - JAK2
  - NFKB1
  - PDCD1
  - REL
  - RELB
  - STAT6
  - TRB
  - NFKBIA
  - TRG
  - TNF
  - TNFAIP3
  - TRAF7
  - TRAF4
  - TRAF5
  - TRAF6
  - HLA-DRB1
  - TRA
  - TRD
  - Rheumatoid arthritis
genes:
- word: IL4R
  symbol: IL4R
  source: hgnc_symbol
  hgnc_symbol: IL4R
  entrez: '3566'
- word: IL4/IL13
  symbol: IL4
  source: hgnc_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: CCR4+
  symbol: CCR4
  source: hgnc_symbol
  hgnc_symbol: CCR4
  entrez: '1233'
- word: CD2
  symbol: CD2
  source: hgnc_symbol
  hgnc_symbol: CD2
  entrez: '914'
- word: CD4/CD8'
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8B
  entrez: '926'
- word: CD4/CD8'
  symbol: CD8
  source: bioentities_symbol
  hgnc_symbol: CD8A
  entrez: '925'
- word: CD58
  symbol: CD58
  source: hgnc_symbol
  hgnc_symbol: CD58
  entrez: '965'
- word: CD4
  symbol: CD4
  source: hgnc_symbol
  hgnc_symbol: CD4
  entrez: '920'
- word: FOXP3
  symbol: FOXP3
  source: hgnc_symbol
  hgnc_symbol: FOXP3
  entrez: '50943'
- word: HLA-DR
  symbol: HLA_DR
  source: bioentities_symbol
  hgnc_symbol: HLA-DRB5
  entrez: '3127'
- word: HLA-DR
  symbol: HLA_DR
  source: bioentities_symbol
  hgnc_symbol: HLA-DRA
  entrez: '3122'
- word: CIITA
  symbol: CIITA
  source: hgnc_symbol
  hgnc_symbol: CIITA
  entrez: '4261'
- word: IKBE
  symbol: IKBE
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIE
  entrez: '4794'
- word: IL4/IL13
  symbol: IL13
  source: hgnc_symbol
  hgnc_symbol: IL13
  entrez: '3596'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF1
  entrez: '7185'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF2
  entrez: '7186'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF3
  entrez: '7187'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: PD1
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: REL
  symbol: REL
  source: hgnc_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: RELB
  symbol: RELB
  source: hgnc_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRB
  entrez: '6957'
- word: IKBa
  symbol: IkappaBalpha
  source: hgnc_alias_symbol
  hgnc_symbol: NFKBIA
  entrez: '4792'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRG
  entrez: '6965'
- word: TNF
  symbol: TNF
  source: hgnc_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: A20
  symbol: A20
  source: hgnc_alias_symbol
  hgnc_symbol: TNFAIP3
  entrez: '7128'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF7
  entrez: '84231'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF4
  entrez: '9618'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF5
  entrez: '7188'
- word: TRAF
  symbol: TRAF
  source: bioentities_symbol
  hgnc_symbol: TRAF6
  entrez: '7189'
- word: HLA-DR
  symbol: HLA_DR
  source: bioentities_symbol
  hgnc_symbol: HLA-DRB1
  entrez: '3123'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRA
  entrez: '6955'
- word: TCR
  symbol: TCR
  source: bioentities_symbol
  hgnc_symbol: TRD
  entrez: '6964'
chemicals: []
diseases:
- word: Rheumatoid arthritis
  source: ''
  identifier: ''
---
